Progesterone Receptor Negative Active Not Recruiting Phase 2 Trials for Palbociclib (DB09073)

IndicationStatusPhase
DBCOND0038639 (Progesterone Receptor Negative)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02774681Palbociclib in Treating Patients With Metastatic HER-2 Positive Breast Cancer With Brain MetastasisTreatment